Aging is the main cause behind most illnesses that eventually kill us. Your chance of dying doubles every 8 years. By the time you turn 80, half of your peers are dead.
However, it turns out aging is a biological process, amenable to treatment. Research has demonstrated that we can postpone the onset of age-related disease. Lab mice know this already. Experiments with caloric restriction, senolytics and metabolic inhibitors have extended life and reversed aging - in mice.
But how do we know these treatments will work in humans? We can wait and see if patients receiving these new treatments die later. Or see if onset of age-related disease is postponed. But this is slow. It takes many, many years to know for sure if the treatments work.
Wouldn’t it be great if we had a faster way?
Thanks to the discovery of the epigenetic clock, we can now accurately describe changes to gene regulation caused by aging. By turning this discovery into a blood test, we can measure the exact aging status inside human cells. This will be incredibly useful to researchers involved in aging research. They would know if a treatment works, much earlier than before. So that’s what we’re making: A biomarker for aging which is accurate, affordable and quick.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Gaustadalléen 21, Startuplab,norway
- Industry
- Biotechnology
- Website
- agelabs.com
- HQ
- Oslo, Oslo
Age Labs As Questions
Age Labs As's website is agelabs.com
Age Labs As's LinkedIn profile is https://no.linkedin.com/company/agelabs
Age Labs As has
4 employees.
View email and phone details for 4
employees at Age Labs As.
Age Labs As's industry is
Biotechnology
Age Labs As's top competitors are
Exact Therapeutics,
Eurofins Norway,
Nykode Therapeutics,
Lytix Biopharma,
Lipum Ab,
Zelluna,
Curida Diatec,
Carrigent,
Skytech Control,
Brave Capital.
Age Labs As's categories are Biotechnology
Age Labs As's founding year is 2017
